“…Finally, the symposium highlighted the importance of including the patient care cascade in the disease spectrum of TB that oscillates from exposure to ‘pre-TB’, active disease and post TB. The incorporation of TB-associated morbidity (post-TB) into National TB Guidelines is also an essential component of comprehensive, patient-centred TB care, as is the development of both international and regional guidelines (e.g., the recent recommendations in Brazil 47 ). Through these steps from advocacy to action, the symposium Steering Committee, academic working groups and delegates aim to improve the long-term health outcomes and quality of life for all children, adolescents and adults that survive TB disease.…”
Section: Discussionmentioning
confidence: 99%
“…Subsequent to the development of PTLD, vaccination against other respiratory pathogens may prevent additional morbidity, 46 and pulmonary rehabilitation may prove to be a low-cost intervention that can be adapted to local conditions. 11 , 12 , 47 …”
Section: Prevention Treatment and Management Of The Post-tb Lung Dise...mentioning
In 2020, it was estimated that there were 155 million survivors of TB alive, all at risk of possible post TB disability. The 2nd International Post-Tuberculosis Symposium (Stellenbosch, South Africa) was held to increase global awareness and empower TB-affected communities
to play an active role in driving the agenda. We aimed to update knowledge on post-TB life and illness, identify research priorities, build research collaborations and highlight the need to embed lung health outcomes in clinical TB trials and programmatic TB care services. The symposium was
a multidisciplinary meeting that included clinicians, researchers, TB survivors, funders and policy makers. Ten academic working groups set their own goals and covered the following thematic areas: 1) patient engagement and perspectives; 2) epidemiology and modelling; 3) pathogenesis of post-TB
sequelae; 4) post-TB lung disease; 5) cardiovascular and pulmonary vascular complications; 6) neuromuscular & skeletal complications; 7) paediatric complications; 8) economic-social and psychological (ESP) consequences; 9) prevention, treatment and management; 10) advocacy, policy and
stakeholder engagement. The working groups provided important updates for their respective fields, highlighted research priorities, and made progress towards the standardisation and alignment of post-TB outcomes and definitions.
“…Finally, the symposium highlighted the importance of including the patient care cascade in the disease spectrum of TB that oscillates from exposure to ‘pre-TB’, active disease and post TB. The incorporation of TB-associated morbidity (post-TB) into National TB Guidelines is also an essential component of comprehensive, patient-centred TB care, as is the development of both international and regional guidelines (e.g., the recent recommendations in Brazil 47 ). Through these steps from advocacy to action, the symposium Steering Committee, academic working groups and delegates aim to improve the long-term health outcomes and quality of life for all children, adolescents and adults that survive TB disease.…”
Section: Discussionmentioning
confidence: 99%
“…Subsequent to the development of PTLD, vaccination against other respiratory pathogens may prevent additional morbidity, 46 and pulmonary rehabilitation may prove to be a low-cost intervention that can be adapted to local conditions. 11 , 12 , 47 …”
Section: Prevention Treatment and Management Of The Post-tb Lung Dise...mentioning
In 2020, it was estimated that there were 155 million survivors of TB alive, all at risk of possible post TB disability. The 2nd International Post-Tuberculosis Symposium (Stellenbosch, South Africa) was held to increase global awareness and empower TB-affected communities
to play an active role in driving the agenda. We aimed to update knowledge on post-TB life and illness, identify research priorities, build research collaborations and highlight the need to embed lung health outcomes in clinical TB trials and programmatic TB care services. The symposium was
a multidisciplinary meeting that included clinicians, researchers, TB survivors, funders and policy makers. Ten academic working groups set their own goals and covered the following thematic areas: 1) patient engagement and perspectives; 2) epidemiology and modelling; 3) pathogenesis of post-TB
sequelae; 4) post-TB lung disease; 5) cardiovascular and pulmonary vascular complications; 6) neuromuscular & skeletal complications; 7) paediatric complications; 8) economic-social and psychological (ESP) consequences; 9) prevention, treatment and management; 10) advocacy, policy and
stakeholder engagement. The working groups provided important updates for their respective fields, highlighted research priorities, and made progress towards the standardisation and alignment of post-TB outcomes and definitions.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.